First read for a new ticker takes about 20–30 seconds while we build the analysis from the latest fundamentals, estimates, and intelligence. It's saved after this, so future visits are instant.
Thesis: Bangkok Dusit Medical Services Public: the story is balanced — International patient volumes and average revenue per medical tourist - recovery toward pre-COVID levels of 15-20%…
★ Analysts see FY2027 revenue reaching $121.7B — +5.3% growth in a single year.
What Moves the Stock
1International patient volumes and average revenue per medical tourist - recovery toward pre-COVID levels of 15-20% revenue contribution drives margin expansion
2Thai baht exchange rate movements - baht depreciation versus USD, EUR, and Middle Eastern currencies makes Thailand more price-competitive for medical tourism
3Domestic middle-class healthcare consumption growth - rising insurance penetration and out-of-pocket spending capacity in Thailand's $505B GDP economy
4New hospital openings and bed capacity additions - $11.7B capex program suggests 8-12 new facilities or major expansions annually across ASEAN markets
5Government healthcare policy changes - universal coverage scheme reimbursement rates and private hospital participation rules affect 70% of Thai population
6Inpatient services (estimated 55-60% of revenue): surgical procedures, intensive care, maternity, oncology treatments across premium hospital network
Rising interest rates create modest headwinds through two channels: (1) 0.19 debt-to-equity ratio indicates $2-3B in outstanding debt where…
Watch on earnings: Thai baht exchange rate (USD/THB) - depreciation improves medical tourism price competitiveness and international patient volumes, Thailand international tourist arrivals - leading indicator for medical tourism demand as 5-8% of tourists seek healthcare services, Thai GDP growth and household consumption expenditure - drives domestic patient volumes and ability to pay premium private hospital rates.
One Sentence Summary:
Bangkok Dusit Medical Services Public: the story is balanced — international patient volumes and average revenue per medical tourist - recovery toward pre-covid levels of 15-20% revenue contribution.
Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.